Shareholders' Equity and Equity Incentive Plans (Tables)
|
9 Months Ended |
Sep. 30, 2026 |
|---|
| Equity [Abstract] |
|
| Summary of Stock Option Activity |
A summary of share option activity under the Company’s equity incentive plans and related information is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding |
|
|
|
Outstanding
Share Options |
|
|
Weighted-Average Exercise
Price |
|
|
Weighted-Average Remaining
Contractual
Life (Years) |
|
|
Aggregate
Intrinsic
Value |
|
|
|
(in thousands, except share, life and per share data) |
|
Outstanding as of December 31, 2025 |
|
|
1,428,546 |
|
|
$ |
10.59 |
|
|
|
3.3 |
|
|
$ |
74,162 |
|
Exercised |
|
|
(666,771 |
) |
|
$ |
8.92 |
|
|
|
|
|
$ |
44,901 |
|
Outstanding and exercisable as of September 30, 2026 |
|
|
761,775 |
|
|
$ |
12.07 |
|
|
|
2.8 |
|
|
$ |
64,732 |
|
|
| Summary of Restricted Ordinary Shares |
A summary of restricted share units (“RSU”) activity under the Company’s equity incentive plan and related information is as follows:
|
|
|
|
|
|
|
|
|
|
|
RSUs |
|
|
|
Unvested RSUs |
|
|
Weighted-Average
Grant Date Fair
Value Per Share |
|
Unvested as of December 31, 2025 |
|
|
9,838,786 |
|
|
$ |
34.76 |
|
Granted |
|
|
2,546,609 |
|
|
$ |
70.74 |
|
Vested |
|
|
(3,713,095 |
) |
|
$ |
33.35 |
|
Forfeited |
|
|
(622,150 |
) |
|
$ |
37.94 |
|
Unvested as of September 30, 2026 |
|
|
8,050,150 |
|
|
$ |
46.54 |
|
|
| Summary of Ordinary Shares Reserved for Future Issuance |
The Company has the following ordinary shares reserved for future issuance:
|
|
|
|
|
|
|
September 30, 2026 |
|
Outstanding share options |
|
|
761,775 |
|
Outstanding RSUs |
|
|
8,050,150 |
|
Issuable ordinary shares related to business combination |
|
|
251,452 |
|
Shares available for future issuance under the 2020 Plan |
|
|
23,143,114 |
|
Shares available for future issuance under ESPP |
|
|
6,421,427 |
|
Total ordinary shares reserved |
|
|
38,627,918 |
|
|
| Summary of Stock-Based Compensation Expense |
The share-based compensation expense by line item in the accompanying Condensed Consolidated Statements of Operations is summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
|
|
(in thousands) |
|
Cost of revenue: subscription–self-managed and SaaS |
|
$ |
4,298 |
|
|
$ |
4,420 |
|
|
$ |
12,467 |
|
|
$ |
12,830 |
|
Research and development |
|
|
14,513 |
|
|
|
15,254 |
|
|
|
42,704 |
|
|
|
43,417 |
|
Sales and marketing |
|
|
14,129 |
|
|
|
14,446 |
|
|
|
39,456 |
|
|
|
40,533 |
|
General and administrative |
|
|
8,853 |
|
|
|
6,740 |
|
|
|
26,370 |
|
|
|
18,934 |
|
Total share-based compensation expense |
|
$ |
41,793 |
|
|
$ |
40,860 |
|
|
$ |
120,997 |
|
|
$ |
115,714 |
|
|